КОМПЛЕКСНАЯ ТЕРАПИЯ ЭПШТЕЙНА-БАРР-ВИРУСНОЙ ИНФЕКЦИИ У ДЕТЕЙ

Abstract

Treatment of patients with infectious mononucleosis is currently difficult because none of the known antiviral drugs can completely eliminate the virus from the organism. Promising is the use of genetically engineered recombinant α-interferon (Viferon®) with a complex antiviral, antibacterial, antiproliferative, and immunomodulatory effects. In our study Viferon® showed high efficiency and was well-tolerated by patients. Viferon® can be recommended for complex treatment of EBV-infected children.

Keywords

• epstein-barr virus
• infectious mononucleosis
• α-interferon
• viferon®